BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31319281)

  • 1. National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project.
    Defourny N; Perrier L; Borras JM; Coffey M; Corral J; Hoozée S; Loon JV; Grau C; Lievens Y
    Radiother Oncol; 2019 Sep; 138():187-194. PubMed ID: 31319281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health economics in radiation oncology: introducing the ESTRO HERO project.
    Lievens Y; Grau C
    Radiother Oncol; 2012 Apr; 103(1):109-12. PubMed ID: 22325993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis.
    Van Dyk J; Zubizarreta E; Lievens Y
    Radiother Oncol; 2017 Nov; 125(2):178-185. PubMed ID: 28947098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-based costing: a practical model for cost calculation in radiotherapy.
    Lievens Y; van den Bogaert W; Kesteloot K
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):522-35. PubMed ID: 12957266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey.
    Lievens Y; Defourny N; Coffey M; Borras JM; Dunscombe P; Slotman B; Malicki J; Bogusz M; Gasparotto C; Grau C; ; Kokobobo A; Sedlmayer F; Slobina E; Coucke P; Gabrovski R; Vosmik M; Eriksen JG; Jaal J; Dejean C; Polgar C; Johannsson J; Cunningham M; Atkocius V; Back C; Pirotta M; Karadjinovic V; Levernes S; Maciejewski B; Trigo ML; Šegedin B; Palacios A; Pastoors B; Beardmore C; Erridge S; Smyth G; Cleries Soler R
    Radiother Oncol; 2014 Aug; 112(2):178-86. PubMed ID: 25300718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey.
    Grau C; Defourny N; Malicki J; Dunscombe P; Borras JM; Coffey M; Slotman B; Bogusz M; Gasparotto C; Lievens Y; ; Kokobobo A; Sedlmayer F; Slobina E; Feyen K; Hadjieva T; Odrazka K; Grau Eriksen J; Jaal J; Bly R; Chauvet B; Willich N; Polgar C; Johannsson J; Cunningham M; Magrini S; Atkocius V; Untereiner M; Pirotta M; Karadjinovic V; Levernes S; Sladowski K; Lurdes Trigo M; Šegedin B; Rodriguez A; Lagerlund M; Pastoors B; Hoskin P; Vaarkamp J; Cleries Soler R
    Radiother Oncol; 2014 Aug; 112(2):155-64. PubMed ID: 25443859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HERO (Health Economics in Radiation Oncology): a pan-European project on radiotherapy resources and needs.
    Lievens Y; Dunscombe P; Defourny N; Gasparotto C; Borras JM; Grau C
    Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):115-24. PubMed ID: 25467072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis.
    Defourny N; Dunscombe P; Perrier L; Grau C; Lievens Y
    Radiother Oncol; 2016 Dec; 121(3):468-474. PubMed ID: 28007378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology.
    Lievens Y; Borras JM; Grau C
    Acta Oncol; 2015; 54(9):1275-81. PubMed ID: 26198650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of radiotherapy in a decade of technology evolution.
    Van de Werf E; Verstraete J; Lievens Y
    Radiother Oncol; 2012 Jan; 102(1):148-53. PubMed ID: 21872955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The financial impact of SBRT for oligometastatic disease: A population-level analysis in Belgium.
    Nevens D; Kindts I; Defourny N; Boesmans L; Van Damme N; Engels H; Van de Voorde C; Lievens Y
    Radiother Oncol; 2020 Apr; 145():215-222. PubMed ID: 32065901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value-based radiotherapy: A new chapter of the ESTRO-HERO project.
    Lievens Y; Borras JM; Grau C; Aggarwal A
    Radiother Oncol; 2021 Jul; 160():236-239. PubMed ID: 33992629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician resource utilization in radiation oncology: a model based on management of carcinoma of the prostate.
    Kobeissi BJ; Gupta M; Perez CA; Dopuch N; Michalski JM; Van Antwerp G; Gerber R; Wasserman TH
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):593-603. PubMed ID: 9486609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How public health services pay for radiotherapy in Europe: an ESTRO-HERO analysis of reimbursement.
    Lievens Y; Defourny N; Corral J; Gasparotto C; Grau C; Borras JM;
    Lancet Oncol; 2020 Jan; 21(1):e42-e54. PubMed ID: 31908306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy access in Belgium: How far are we from evidence-based utilisation?
    Lievens Y; De Schutter H; Stellamans K; Rosskamp M; Van Eycken L;
    Eur J Cancer; 2017 Oct; 84():102-113. PubMed ID: 28802187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey.
    Dunscombe P; Grau C; Defourny N; Malicki J; Borras JM; Coffey M; Bogusz M; Gasparotto C; Slotman B; Lievens Y; ; Kokobobo A; Sedlmayer F; Slobina E; De Hertogh O; Hadjieva T; Petera J; Grau Eriksen J; Jaal J; Bly R; Azria D; Baumann M; Takacsi-Nagy Z; Johannson J; Cunningham M; Magrini S; Atkocius V; Untereiner M; Pirotta M; Karadjinovic V; Levernes S; Reinfuss M; Trigo ML; Cernea V; Dubinsky P; Šegedin B; Lopez Torrecilla J; Pastoors B; Taylor R; Taylor S
    Radiother Oncol; 2014 Aug; 112(2):165-77. PubMed ID: 25245560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
    Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
    Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project.
    Bentzen SM; Heeren G; Cottier B; Slotman B; Glimelius B; Lievens Y; van den Bogaert W
    Radiother Oncol; 2005 Jun; 75(3):355-65. PubMed ID: 16086915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost accounting in radiation oncology: a computer-based model for reimbursement.
    Perez CA; Kobeissi B; Smith BD; Fox S; Grigsby PW; Purdy JA; Procter HD; Wasserman TH
    Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):895-906. PubMed ID: 8478242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.